These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9919455)

  • 1. Omeprazole and the development of acute hepatitis.
    Koury SI; Stone CK; La Charité DD
    Eur J Emerg Med; 1998 Dec; 5(4):467-9. PubMed ID: 9919455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hepatitis induced by omeprazole.
    Koury SI; Stone CK; La Charité DD
    Am J Emerg Med; 1998 Sep; 16(5):550-1. PubMed ID: 9725985
    [No Abstract]   [Full Text] [Related]  

  • 3. Omeprazole-induced hepatitis.
    El-Matary W; Dalzell M
    Pediatr Emerg Care; 2005 Aug; 21(8):529-30. PubMed ID: 16096600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hepatitis related to omeprazole.
    Romero-Gómez M; Otero MA; Suárez-García E; García Díaz E; Fobelo MJ; Castro-Fernández M
    Am J Gastroenterol; 1999 Apr; 94(4):1119-20. PubMed ID: 10201510
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrent severe acute hepatitis and omeprazole.
    Navarro JF; Gallego E; Avilés J
    Ann Intern Med; 1997 Dec; 127(12):1135-6. PubMed ID: 9412333
    [No Abstract]   [Full Text] [Related]  

  • 6. [Omeprazole-induced acute cholestatic hepatitis].
    Sánchez Garrido A
    Gastroenterol Hepatol; 2007 Jan; 30(1):54. PubMed ID: 17266883
    [No Abstract]   [Full Text] [Related]  

  • 7. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of gastric fundic polyps during long-term treatment of reflux esophagitis with omeprazole].
    Yamamoto T; Matsumoto J; Kosaihira T; Nomoto M; Kitajima S; Arima T
    Nihon Shokakibyo Gakkai Zasshi; 2003 Apr; 100(4):421-5. PubMed ID: 12722347
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of recurrent erosive reflux esophagitis].
    Müller P; Simon B
    Fortschr Med; 1997 Oct; 115(30):46-7. PubMed ID: 9453943
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute renal failure due to omeprazole.
    O'Donnell D
    Med J Aust; 1996 Aug; 165(4):234-5. PubMed ID: 8773659
    [No Abstract]   [Full Text] [Related]  

  • 11. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Arnold R
    Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
    [No Abstract]   [Full Text] [Related]  

  • 12. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lansoprazole-induced hepatitis].
    Viana de Miguel C; Alvarez García M; Sánchez Sánchez A; Carvajal García-Pando A
    Med Clin (Barc); 1997 Apr; 108(15):599. PubMed ID: 9280798
    [No Abstract]   [Full Text] [Related]  

  • 14. Reflux oesophagitis and acid exposure.
    Ransford R
    Gut; 1996 Dec; 39(6):889. PubMed ID: 9038679
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E
    Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease.
    Armstrong D
    Lancet; 2000 Aug; 356(9230):610-2. PubMed ID: 10968429
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lansoprazole hypersensitivity syndrome].
    Baudot S; Milpied-Homsi B; Andres P; Poirier Y; Larousse C
    Therapie; 1999; 54(4):491-3. PubMed ID: 10667118
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term therapy with omeprazole: when will it finally be approved?].
    Koop H
    Leber Magen Darm; 1995 Jul; 25(4):153-4. PubMed ID: 7564865
    [No Abstract]   [Full Text] [Related]  

  • 19. Omeprazole-induced leukopenia. A case report.
    Odou P; Martin P; Membré S; Gressier B; Tamiji L; Dine T; Luyckx MM; Brunet C; Dehee D; Moulron S
    J Clin Pharm Ther; 1999 Oct; 24(5):317-21. PubMed ID: 10583693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing concerns about chronic proton pump inhibitor use.
    Svoboda AC
    J Clin Gastroenterol; 2001 Jul; 33(1):3-7. PubMed ID: 11418781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.